To bring quality cancer treatment closer to patients, India’s leading MedTech brand is joining forces with the unique technology-led platform
CHENNAI: About 20 lakh new cancer cases were reported in India last year, while the actual occurrence is considered to 1.5 to 3 times higher, states a FICCI report. To make quality cancer treatment accessible and affordable for everyone, Johnson & Johnson MedTech India is joining hands with Karkinos Healthcare, an end-to-end technology platform, to pursue opportunities in upskilling healthcare professionals in cancer care.
Access to specialized care of oncologists is significantly constrained in India. The country has a shortfall of over 3000 medical oncologists and 800 surgical oncologists. To bridge the gap, Johnson & Johnson has been investing in upskilling surgeons through its physical and mobile institutes, and tie-ups with Centers of Excellence. The Johnson & Johnson Institute currently offers more than 225 online assets in 25 curriculums, covering 11 surgical specialties. Surgeons enjoy a connected experience through new age learning formats like artificial intelligence, virtual reality, and telemedicine. The partnership aims to combine this digital learning methodology with Karkinos’ expertise of enabling hospitals in setting up comprehensive cancer care systems. Together, both the organizations will develop futuristic programs and infrastructure for the skill upgradation of healthcare professionals in a variety of capacities and capabilities needed for comprehensive cancer treatment.
